Trials / Completed
CompletedNCT04491773
Study of Retinal and Choriocapillary Vascular Changes in Patients Undergoing Tadalafil 20mg for More Than 6 Months
Evaluation of Retinal and Choriocapillary Vascular Changes Using Optical Coherence Tomography Angiography in Patients Undergoing Tadalafil 20mg on Alternative Days for More Than 6 Months: a Single-centre Prospective-control
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 54 (actual)
- Sponsor
- Federico II University · Academic / Other
- Sex
- Male
- Age
- 45 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluates the retinal and choriocapillary vascular features in patients under the effects of Tadalafil 20mg for more than 6 months, using optical coherence tomography angiography.
Detailed description
Tadalafil is a an inhibitor of the enzyme phosphodiesterase and it works by increasing blood flow to the penis thus promoting the erection. This drug represents an treatment for erectile dysfunction in patients after radical prostatectomy. The optical coherence tomography angiography represents a novel and noninvasive diagnostic technique that allows a detailed and quantitative analysis of retinal and choriocapillary vascular features. The study evaluates the changes in optical coherence tomography angiography features after the somministration of Tadalafil 20 mg orally for more than 6 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tadalafil 20 MG | To study retinal and choriocapillary features in patients undergoing Tadalafil 20 mg orally, on alternate days, for more than 6 months. |
Timeline
- Start date
- 2019-11-01
- Primary completion
- 2020-05-25
- Completion
- 2020-05-30
- First posted
- 2020-07-29
- Last updated
- 2020-07-29
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT04491773. Inclusion in this directory is not an endorsement.